Business
Change of broker
Change of broker.
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 3118L\n OptiBiotix Health PLC\n 12 January 2021\n \n \n \n \n OptiBiotix Health plc\n \n \n (\n \n \"OptiBiotix\" or the \"Company\")\n \n \n \n \n \n \n Appointment of Broker\n \n \n \n \n \n OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare,announces \n the appointment of Cenkos Securities plc as its sole broker with immediate effect.\n \n \n \n \n \n For further information, please contact:\n \n \n \n \n \n \n \n \n OptiBiotix Health plc\n \n \n \n \n \n www.optibiotix.com\n \n \n \n \n \n \n \n Neil Davidson, Chairman\n \n \n \n \n Contact via Walbrook below\n \n \n \n \n \n \n Stephen O'Hara, Chief Executive\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Cairn Financial Advisers LLP (NOMAD)\n \n \n \n \n Tel: 020 7213 0880\n \n \n \n \n \n \n Liam Murray / Jo Turner / Ludovico Lazzaretti\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Cenkos Securities plc (Broker)\n \n \n \n \n Tel: 020 7397 8900\n \n \n \n \n \n \n Callum Davidson / Neil McDonald\n \n \n \n \n \n \n \n \n \n \n \n \n \n Michael Johnson / Russell Kerr (Sales)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Walbrook PR Ltd\n \n \n \n \n Mob: 07876 741 001\n \n \n \n \n \n \n Anna Dunphy\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About OptiBiotix\n \n - \n \n www.optibiotix.com\n \n \n \n \n \n OptiBiotix Health plc (AIM: OPTI) is a biotechnology company formed in March 2012 which, brings science and human stuidies to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.\n \n \n OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than seventy international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide r...